Account

Table 2 DXR/LV in combination achieving 50% inhibitory

From: Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

DXR (μM)	LV (μM)	LV (μM)	DXR (μM)
0	10.07	0	0.865
0.005	9.387	0.1	0.993
0.025	7.090	0.3	1.069
0.125	10.92	1.0	1.005
0.625	0.28	3.0	0.3033
3.125	0.0004085	10.0	0.007196

Back to article page